Breaking Finance News

BREAKING- Teva Pharmaceuticals Spiking On News the FDA Gave it Exclusive Rights to ‘Plan B’

Shares of Teva Pharmaceuticals (NYSE: TEVA) spiked around 10:15 a.m. presumably after news broke that the FDA gave it three years of market exclusivity on its emergency contraception drug, Plan B One-Step. Raps.org reported the story under the headline, “After Confusing Approval Process, FDA Confirms Teva’s Plan B One-Step will get Exclusive Rights.

[stock-tools exchange="NYSE" symbol="TEVA" image_height="230" image_width="350"]

Disclosure: At the time of this writing, the author had no position in the company mentioned.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.